Accordingly, further mechanistic investigations showed that LINC00494 recruited transcription factor NFκB1 to bind on the promoter region of FBXO32, which inhibited the transcription of FBXO32, while suppressing the progression and development of ovarian cancer. This evidence concerns the gene NFKB1 and ovarian carcinoma.